mHealth Apps

mHealth Apps Market Value is Estimated to be US$ 240.65 Bn by 2027 mHealth Apps Market (By Type: Nutrition & Diet, Women's Health, Medication Adherence, Fitness, Lifestyle Management, Healthcare, Providers/Payers, Disease Management, and Others) - Global Market Size, Trends Analysis, Segment Forecasts, Regional Outlook 2020 - 2027

Share This Article

[150+ Pages Report] The mHealth apps market size in terms of value is projected to reach $240.65  billion by 2027, Growing at a CAGR of 43.9% between 2020 and 2027, according to a 2021 study by Precedence Research, the Canada based market insight company.

The study provides the overall revenue of the global mHealth apps market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

The global mHealth apps market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the mHealth apps industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST SAMPLE OR CUSTOMIZED COPY OF THIS REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1061

Growth Factors

Augmented expenditure by the healthcare participants and escalating emphasis on ailment management and precautionary care has stimulated the active participation of healthcare consultants and patients across the medical care and hospitals. The extraordinary growth of mobile technologies as well as advancements in their innovative application concerning health priorities have evolved across the globe, which has resulted in creating numerous opportunities in the field of eHealth. In addition to this, the health consciousness across the global population has been drastically increased, creating extensive demand for e-Health services. In the recent years, the traditional health service provider-centric modules have been replaced by patient-centric care modules, complementary to this, the use of mHealth applications has reduced the time required and increased the smoothness in ongoing healthcare operations.

Recently, the use of wearable devices has been considerably increased. Since, these devices are designed for the prevention of diseases and maintenance of health, such as weight control and physical activity monitoring. Many of these devices are also used for disease and patient management. Furthermore, government support as well as assistance from global health organizations such as WHO and many others will further complement the growth of the mHealth apps market. The growing prevalence of numerous chronic disorders and numerous other diseases like diabetes, hypertension, and cancer will further upsurge the demand for mHealth applications. However, compatibility, reliability, and uncertainty of some of the mHealth applications might restrict the market growth.

Report Scope of the mHealth Apps Market

Report Highlights Details
Market Size USD 240.65 Billion by 2027
Growth Rate CAGR of 43.9% from 2020 to 2027
Fastest Growing Market Asia Pacific
Largest Market North America
Base Year 2021
Forecast Period 2020 to 2027
Segments Covered Type, Region
Companies Mentioned F. Hoffmann-La Roche Ltd., AstraZeneca PLC,Johnson and Johnson, Sanofi.,iHealth Labs Inc., Bristol-Myers Squibb Company, Vivify Health, Abbott Laboratories, Medtronic MiniMed, Inc.

Report Highlights

  • Presently, due to unhealthier lifestyles across the global population prevalence of chronic diseases has increased the demand for mHealth applications.
  • Increasing assistance from global healthcare organizations likes WHO and government support has created a favorable environment for the mHealth application market development.
  • Healthcare service providers and Physicians are increasingly recommending the use of mHealth applications resulted in upsurges adoption rates and the number of users.
  • North American mHealth apps market has dominated in the years 2020 with respect to comparatively strengthening technological and healthcare infrastructure.
  • The COVID19 pandemic has drastically affected the mHealth apps market dynamics to a significant extent. Since the majority of the market and leading countries are drastically impacted by the ongoing pandemic.

Regional Snapshots

Considering the income-based regional classifications, the higher income countries show comparatively additional adoption of mHealth applications than the lower-income countries. As a result, countries across North America and Europe show greater than the African and Middle Eastern countries. On the other hand, growing mobile users across India, China, Japan, and other developing countries from Asia has shown a drastic increase in the adoption of mHealth applications. However, North America is the dominant region based on the regional segmentation concerning the available technological and corresponding health infrastructure.

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global mHealth apps market are as follows:

  • Abbott Laboratories
  • Johnson and Johnson
  • AstraZeneca PLC
  • Hoffmann-La Roche Ltd.
  • Novartis AG
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck and Co., Inc.
  • Pfizer, Inc.
  • iHealth Labs Inc.
  • Vivify Health
  • Medtronic MiniMed, Inc.

Market Segmentation

By Type

  • Nutrition & Diet
  • Women’s Health
  • Medication Adherence
  • Fitness
  • Lifestyle Management
  • Healthcare Providers/Payers
  • Disease Management
  • Others

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights of the report are:

  • Market Demand Outlook – The report offers refined forecasts on potential growth prospects for the market. Based on data derived after thorough research by a team of expert analysis, Precedence Research presents the most precise rate of growth for the market for the assessment period starting from 2020 – 2027.
  • Supply Chain Analysis – The purpose of the survey is to help companies identify potential scope for supply chain expansion. The study also presents analysis of unprecedented threats.
  • Competitive Landscape Analysis – Some of the leading companies operating in the mHealth apps market are profiled in the market study. The report also underscores winning strategies adopted over the last few years and gauges impact of the same on growth trajectory exhibited by the market over the last few years.

Why should you invest in this report?

If you are aiming to enter the global mHealth apps market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for mHealth apps are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2020-2027 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global mHealth Apps Market, By Type

7.1. mHealth Apps Market, by Type, 2020-2027
7.1.1. Nutrition & Diet
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Women’s Health
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Medication Adherence
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Fitness
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Lifestyle Management
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Healthcare Providers/Payers
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Disease Management
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2016-2027)

Chapter 8. Global mHealth Apps Market, Regional Estimates and Trend Forecast

8.1. North America
8.1.1. Market Revenue and Forecast, by Type (2016-2027)
8.1.2. U.S.
8.1.3. Rest of North America
8.1.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.2. Europe
8.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.2. UK
8.2.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.3. France
8.2.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.2.4. Rest of Europe
8.2.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.3. APAC
8.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.2. India
8.3.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.3. China
8.3.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.4. Japan
8.3.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.3.5. Rest of APAC
8.3.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.4. MEA
8.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.2. GCC
8.4.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.3. North Africa
8.4.3.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.4. South Africa
8.4.4.1. Market Revenue and Forecast, by Type (2016-2027)
8.4.5. Rest of MEA
8.4.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.5. Latin America
8.5.1. Market Revenue and Forecast, by Type (2016-2027)
8.5.2. Brazil
8.5.2.1. Market Revenue and Forecast, by Type (2016-2027)
8.5.3. Rest of LATAM
8.5.3.1. Market Revenue and Forecast, by Type (2016-2027)

Chapter 9. Company Profiles

9.1. Abbott Laboratories
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Johnson and Johnson
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. AstraZeneca PLC
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Hoffmann-La Roche Ltd.
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Novartis AG
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Bristol-Myers Squibb Company
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. GlaxoSmithKline plc
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
9.8. Merck and Co., Inc.
9.8.1. Company Overview
9.8.2. Product Offerings
9.8.3. Financial Performance
9.8.4. Recent Initiatives
9.9. Pfizer, Inc.
9.9.1. Company Overview
9.9.2. Product Offerings
9.9.3. Financial Performance
9.9.4. Recent Initiatives
9.10. iHealth Labs Inc.
9.10.1. Company Overview
9.10.2. Product Offerings
9.10.3. Financial Performance
9.10.4. Recent Initiatives
9.11. Vivify Health
9.11.1. Company Overview
9.11.2. Product Offerings
9.11.3. Financial Performance
9.11.4. Recent Initiatives
9.12. Medtronic MiniMed, Inc.
9.12.1. Company Overview
9.12.2. Product Offerings
9.12.3. Financial Performance
9.12.4. Recent Initiatives

Chapter 10. Research Methodology

10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions

Chapter 11. Appendix

11.1. About Us
11.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1061

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →